Aggressiveness of Intensive Care Use Among Patients With Lung Cancer in the Surveillance, Epidemiology, and End Results-Medicare Registry

被引:23
|
作者
Cooke, Colin R. [1 ]
Feemster, Laura C. [2 ,3 ]
Wiener, Renda Soylemez [4 ,5 ]
O'Neil, Maya E. [6 ,7 ]
Slatore, Christopher G. [6 ,7 ,8 ,9 ]
机构
[1] Univ Michigan, Ctr Healthcare Outcomes & Policy, Inst Healthcare Innovat & Policy, Div Pulm & Crit Care Med,Michigan Ctr Integrat Re, Ann Arbor, MI 48109 USA
[2] VA Puget Sound Healthcare Syst, Div Pulm & Crit Care Med, Seattle, WA USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Boston Univ, Sch Med, Boston, MA 02118 USA
[5] Edith Nourse Rogers Mem VA Hosp, Bedford, MA USA
[6] Portland VA Med Ctr, Hlth Serv Res, Portland, OR USA
[7] Portland VA Med Ctr, Hlth Serv Dev, Portland, OR USA
[8] Portland VA Med Ctr, Sect Pulm & Crit Care Med, Portland, OR USA
[9] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA
基金
美国医疗保健研究与质量局;
关键词
OF-LIFE CARE; OUTCOMES; BENEFICIARIES; TRENDS; UNITS;
D O I
10.1378/chest.14-0477
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Approximately 65% of elderly patients with lung cancer who are admitted to the ICU will die within 6 months. Efforts to improve end-of-life care for this population must first understand the patient factors that underlie admission to the ICU. METHODS: We performed a retrospective cohort study examining all fee-for-service inpatient claims in the Surveillance, Epidemiology, and End Results (SEER)-Medicare registry for elderly patients (aged. 65 years) who had received a diagnosis of lung cancer between 1992 and 2005 and who were hospitalized for reasons other than resection of their lung cancer. We calculated yearly rates of ICU admission per 1,000 hospitalizations via room and board codes or International Classification of Diseases, Ninth Revision, Clinical Modification and diagnosis-related group codes for mechanical ventilation, stratified the rates by receipt of mechanical ventilation and ICU type (medical/surgical/cardiac vs intermediate), and compared these rates over time. RESULTS: A total of 175,756 patients with lung cancer in SEER were hospitalized for a reason other than surgical resection of their tumor during the study period, 49,373 (28%) of whom had at least one ICU stay. The rate of ICU admissions per 1,000 hospitalizations increased over the study period from 140.7 in 1992 to 201.7 in 2005 (P < .001). The majority of the increase in ICU admissions (per 1,000 hospitalizations) between 1992 and 2005 occurred among patients who were not mechanically ventilated (118.2 to 173.3, P < .001) and among those who were in intermediate ICUs (20.0 to 61.9, P < .001), but increased only moderately in medical/surgical/cardiac units (120.7 to 139.9, P < .001). CONCLUSIONS: ICU admission for patients with lung cancer increased over time, mostly among patients without mechanical ventilation who were largely cared for in intermediate ICUs.
引用
收藏
页码:916 / 923
页数:8
相关论文
共 50 条
  • [21] Trends in the use of postprostatectomy therapies for patients with prostate cancer: A Surveillance, Epidemiology, and End Results Medicare analysis
    Sheets, Nathan C.
    Hendrix, Laura H.
    Allen, Ian M.
    Chen, Ronald C.
    CANCER, 2013, 119 (18) : 3295 - 3301
  • [22] Acute Leukemia of Ambiguous Lineage in Elderly Patients - Analysis of Survival Using Surveillance Epidemiology and End Results-Medicare Database
    Murthy, Guru Subramanian Guru
    Dhakal, Ishwori
    Lee, Jeanette Y.
    Mehta, Paulette
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (02): : 100 - 107
  • [23] Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study
    Duchesneau, Emilie D.
    Mcneill, Ann Marie
    Schary, William
    Pate, Virginia
    Lund, Jennifer L.
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (08)
  • [24] Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data
    Danese, Mark D.
    Daumont, Melinda
    Nwokeji, Esmond
    Gleeson, Michelle
    Penrod, John R.
    Lubeck, Deborah
    CANCER REPORTS, 2022, 5 (09)
  • [25] Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data
    Lane, Giulia
    Risk, Michael
    Fan, Yunhua
    Krishna, Suprita
    Konety, Badrinath
    BJU INTERNATIONAL, 2019, 123 (05) : 818 - 825
  • [26] Risk of second lung cancer in patients with previously treated lung cancer: Analysis of the Surveillance, Epidemiology and End Results (SEER) registry
    Sivakumaran, P.
    Gadgeel, S. M.
    Schwartz, A.
    Vigneau, F.
    Islam, K.
    Wozniak, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program
    Healy, Mark A.
    Morris, Arden M.
    Abrahamse, Paul
    Ward, Kevin C.
    Kato, Ikuko
    Veenstra, Christine M.
    BMC CANCER, 2018, 18
  • [28] Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis
    Xiang, Michael
    Holsinger, F. Christopher
    Colevas, A. Dimitrios
    Chen, Michelle M.
    Quynh-Thu Le
    Beadle, Beth M.
    CANCER, 2018, 124 (23) : 4486 - 4494
  • [29] The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program
    Mark A. Healy
    Arden M. Morris
    Paul Abrahamse
    Kevin C. Ward
    Ikuko Kato
    Christine M. Veenstra
    BMC Cancer, 18
  • [30] Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results-medicare
    Schrag, D
    Gelfand, SE
    Bach, PB
    Guillem, J
    Minsky, BD
    Begg, CB
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) : 3712 - 3718